Citius Acquires License Of E7777 For All Markets Excl. Certain Parts Of Asia, Japan

Citius Pharmaceuticals, Inc. (CTXR) has entered into a definitive agreement with Dr. Reddy's Laboratories SA (RDY) to acquire its exclusive license of E7777, a late-stage oncology immunotherapy for the treatment of cutaneous T-cell lymphoma. Citius will acquire Dr. Reddy's exclusive license of E7777 from Eisai Co. and other related assets owned by Dr. Reddy's.

Dr. Reddy's will receive a $40 million upfront payment and is entitled to up to $40 million in development milestone payments related to cutaneous T-cell lymphoma approvals in the U.S. and other markets, up to $70 million in development milestones for additional indications, as well as commercial milestone payments and low double-digit tiered royalties on net product sales.

Citius's exclusive license rights include rights to develop and commercialize E7777 in all markets except for Japan and certain parts of Asia. Citius will also retain an option on the right to develop and market the product in India.

E7777, a purified version of denileukin diftitox, is a reformulation of ONTAK. ONTAK, marketed in the U.S. from 2008 to 2014, was voluntarily withdrawn to enable manufacturing improvements.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Specialty athletic retailer Foot Locker, Inc. reported Friday a second-quarter net profit that plunged from last year, hurt by a sales decline amid markdowns. Quarterly sales met Street estimates. The company also trimmed it adjusted earnings and sales growth guidance for the full-year 2022. Google's hundreds of employees have signed a petition sent to executives demanding extension of abortion care benefits to contract workers. The workers also called to halt donations given to anti-abortion politicians and to expand travel benefits. The petition, circulated by the Alphabet Workers Union, has been signed by over 650 employees at Google's parent company Alphabet Inc. Apple Inc. has released an emergency security update noting that some of its iPhones, iPads and Macs had certain vulnerabilities. The tech major said the flaws potentially allow full admin access to devices. The models affected by the issue include iPhone 6S and later models, several models of the newer iPads, and Mac computers running macOS Monterey and above. The flaws also affect the iPod Touch
Follow RTT